This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1992 Dec 10;327(24):1729-33.

doi: 10.1056/NEJM199212103272406.

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

W P Fay¹, A D Shapiro, J L Shih, R R Schleef, D Ginsburg

Affiliations

PMID: 1435917
DOI: 10.1056/NEJM199212103272406

Free article

Case Reports

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

W P Fay et al. N Engl J Med. 1992.

Free article

. 1992 Dec 10;327(24):1729-33.

doi: 10.1056/NEJM199212103272406.

Authors

W P Fay¹, A D Shapiro, J L Shih, R R Schleef, D Ginsburg

Affiliation

¹ Cardiology Division, Ann Arbor Veterans Affairs Hospital, Mich.

PMID: 1435917
DOI: 10.1056/NEJM199212103272406

No abstract available

PubMed Disclaimer

Similar articles

[Report of a case of congenital plasminogen activator inhibitor-1 deficiency].
Zhang ZY, Wang ZY, Fu JX, Dong NZ, Zhang W, Bai X, Ruan CG. Zhang ZY, et al. Zhonghua Xue Ye Xue Za Zhi. 2004 Mar;25(3):129-31. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15182577 Chinese.
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V. Biermann JC, et al. Int J Mol Med. 2008 Feb;21(2):251-9. Int J Mol Med. 2008. PMID: 18204793
Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH, Martin TJ. Allan EH, et al. J Cell Physiol. 1995 Dec;165(3):521-9. doi: 10.1002/jcp.1041650310. J Cell Physiol. 1995. PMID: 7593231
[Plasminogen activator inhibitor deficiency].
Mimuro J. Mimuro J. Ryoikibetsu Shokogun Shirizu. 1998;(21 Pt 2):494-7. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9833553 Review. Japanese. No abstract available.
Plasminogen activator inhibitor type 1 deficiency.
Mehta R, Shapiro AD. Mehta R, et al. Haemophilia. 2008 Nov;14(6):1255-60. doi: 10.1111/j.1365-2516.2008.01834.x. Haemophilia. 2008. PMID: 19141166 Review.

See all similar articles

Cited by

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.
Singh S, Kumar P, Padwad YS, Jaffer FA, Reed GL. Singh S, et al. Circulation. 2024 Sep 10;150(11):884-898. doi: 10.1161/CIRCULATIONAHA.124.069728. Epub 2024 Sep 9. Circulation. 2024. PMID: 39250537 Review.
Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.
Wohner N, Kovács A, Machovich R, Kolev K. Wohner N, et al. Thromb Res. 2012 Apr;129(4):e41-6. doi: 10.1016/j.thromres.2011.11.021. Epub 2011 Dec 15. Thromb Res. 2012. PMID: 22178067 Free PMC article.
Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.
Saes JL, Schols SEM, Betbadal KF, van Geffen M, Verbeek-Knobbe K, Gupta S, Hardesty BM, Shapiro AD, van Heerde WL. Saes JL, et al. Haemophilia. 2019 Nov;25(6):1073-1082. doi: 10.1111/hae.13842. Epub 2019 Aug 30. Haemophilia. 2019. PMID: 31469483 Free PMC article.
Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.
Vaughan DE. Vaughan DE. J Thromb Thrombolysis. 1995;2(3):187-193. doi: 10.1007/BF01062709. J Thromb Thrombolysis. 1995. PMID: 10608023
Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.
Ploplis VA. Ploplis VA. Curr Drug Targets. 2011 Nov;12(12):1782-9. doi: 10.2174/138945011797635803. Curr Drug Targets. 2011. PMID: 21707474 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Molecular Biology Databases
- The Weizmann Institute of Science GeneCards and MalaCards databases